glp-1 cardiovascular outcomes news and mortality with receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Targeting the weight within: obesity

The role of endocannabinoid signaling in motor control

PlexusDx's Precision Peptide Genetic Test screens variants like GLP1R rs6923761, GIPR rs1800437, and FTO rs9939609 that predict appetite rebound intensity and long-term semaglutide need

Each time it washes over your teeth, it erodes enamel , the protective shell around your teeth

One of their areas of investigation was the type and duration of side effects between the two groups

If looking to use a GLP-1 for help with weight loss, you will start with what is essentially a micro-dose: you start on the lowest .25mg dose of semaglutide and then gradually increase the dosing as tolerated, and as needed, as long as it dovetails with your weight loss goals

GLP-1 receptor agonist medications slow gastric emptying, which further contributes to a feeling of satiety and reduces oral intake